Ocena postępowania diagnostycznego i terapeutycznego w ...

181. Marculescu R, le T, Simon P, Jaeger U, Nadel B. V (D)J-mediated translocations in lymphoid
neoplasms: a functional assessment of genomic instability by cryptic sites. J Exp Med. 2002;
195: 85-98.
182. Marculescu R., Vanura K, Montpellier B i wsp. Recombinase, chromosomal translocations
and lymphoid neoplasia: Targeting mistakes and repair failures. DNA Repair. 2006; 5:
1246-58.
183. Bredemeyer AL, Sharma GG, Huang CY i wsp. ATM stabilizes DNA double-strand-break
complexes during V(D)J recombination. Nature. 2006; 442: 466-70.
184. Dinkelmann M, Spehalski E, Stoneham T i wsp. Multiple functions of MRN in end-joining
pathways during isotype class switching. Nat Struct Mol Biol. 2009;16: 808-13.
185. De Jong D, Glass A, Boerrigter L i wsp. Very late relapse in diffuse large B-cell lymphoma
represents clonally related disease and is marked by germinal center cell features. Blood.
2003; 102; 324-327.
186. Lenz G, Wright GW, Emre NC. Molecular subtypes of diffuse large B-cell lymphoma arise by
distinct genetic pathways. Proc Natl Acad Sci USA. 2008; 105: 13520–25.
187. Lahdesmaki A, Taylor AM, Chrzanowska KH, Pan-Hammarstrom Q. Delineation of the role
of the Mre11 complex in class switch recombination. J. Biol. Chem 2004; 279: 16479–87.
188. Barrans SL, Carter I, Owen RG i wsp. Germinal center phenotype and bcl-2 expression
combined with the International Prognostic Index improves patient risk stratification in diffuse
large B-cell lymphoma. Blood. 2002; 99: 1136-43.
189. Wróbel G, Kazanowska B, Chybicka A i wsp. Raport Polskiej Pediatrycznej Grupy ds.
Leczenia Białaczek i Chłoniaków Złośliwych u Dzieci. Część II. Przyczyny niepowodzeń w
leczeniu nieziarniczych chłoniaków limfoblastycznych linii T- komórkowej u dzieci na
podstawie wieloośrodkowych badań klinicznych. Adv Clin Exp Med. 2004; 13: 921-25.
190. Patte C, Auperin A, Gerrard M i wsp. Results of the randomized international FAB/LMB96
trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is
possible to reduce treatment for the early responding patients. Blood. 2007; 109: 2773-80.
191. Zając-Spychała O, Derwich K, Mańkowska M i wsp. Analysis of prognostic factors in
children with B-cell non-Hodgkin lymphoma. Med Wieku Rozwoj. 2008; 12: 1087-91.
192. Bouafia F, Drai J, Bienvenu J i wsp. Profiles and prognostic values of serum LDH isoenzymes
in patients with haematopoietic malignancies. Bull Cancer. 2004; 91: 229-40.
193. Mora J, Wollner N. Primary epidural non-Hodgkin lymphoma: spinal cord compression
syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma. Med
Pediatr Oncol. 1999; 32: 102-05.
194. Chahal S, Lagera JE, Ryder J, Kleinschmidt-DeMasters BK. Hematological neoplasms with
first presentation as spinal cord compression syndromes: a 10-year retrospective series and
review of the literature. Clin Neuropathol. 2003; 22: 282-90.
195. Ses E, N'dri Oka D, Varlet G i wsp. Medullary compression by Burkitt lymphoma. Analysis of
7 cases. Neurochirurgie. 2001; 47: 552-56.
196. Daley MF, Partington MD, Kadan-Lottick N, Odom LF. Primary epidural Burkitt lymphoma
in a child: case presentation and literature review. Pediatr Hematol Oncol. 2003; 20: 333-38.
197. Bekar A, Cordan T, Evrensel T, Tolunay S. A case of primary spinal intramedullary
lymphoma. Surg Neurol. 2001; 55: 261-64.
198. Van Engelem B, Hiel J, Gabreels F i wsp. Decreased immunoglobulin class switching in
Nijmegen breakage syndrome due to the DNA repair defect. Hum Immun. 2001; 62: 1324-27.
199. Gennery A, O’Driscoll M. Unravelling the web of DNA repair disorders. Clin Exp Immunol.
2003; 134: 385-87.
200. Gracia-Perez M, Allende L, Corelli A i wsp. Role of Nijmegen breakage syndrome protein in
specyfic T-lymphocyte activation pathways. Clin. Diagn. Lab. Immunol. 2001; 8: 757–61.
201. Paganelli R, Scala E, Scarselli E i wsp. Selective deficiency of CD41/CD45RA1 lymphocytes
in patients with ataxia-telangiectasia. J Clin Immunol. 1992; 12: 84–91.
202. Akha AAS, Humphrey RL, Winkelstein JA i wsp. Oligo-/monoclonal gammopathy and
hypergammaglobulinemia in ataksia-teleangiectasia. Medicine. 1999; 78: 370-81.
203. Sobol G, Mizia A, Małdyk J i wsp. Zespół Nijmegen z limfadenopatią nawrotową – dylematy
diagnostyczne. Pediatr Pol. 2003; 78: 625-28.
145